JP Patent

JP5024635B2 — 睡眠覚醒障害の治療

Assigned to エスケーバイオファーマスティカルズカンパニーリミテッド · Expires 2012-09-12 · 14y expired

What this patent protects

Patent listed against solriamfetol-hydrochloride.

Drugs covered by this patent

solriamfetol-hydrochloride (SOLRIAMFETOL HYDROCHLORIDE)

Patent Metadata

Patent number: JP5024635B2
Jurisdiction: JP
Classification: —
Expires: 2012-09-12
Drug substance claim: No
Drug product claim: No
Assignee: エスケーバイオファーマスティカルズカンパニーリミテッド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.